Lv1
42 积分 2023-04-20 加入
.Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T‐cell and natural killer‐cell neoplasms: a phase 2, multicenter, open‐label, single‐arm trial
6天前
已完结
Venetoclax combined with homoharringtonine, cytarabine and aclacinomycin as induction therapy in newly diagnosed Chinese acute myeloid leukaemia patients: A multicentre phase II study
16天前
已完结
Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
1个月前
已完结
Artificial intelligence in myeloid malignancies: Clinical applications of machine learning in myelodysplastic syndromes and acute myeloid Leukemia
1个月前
已完结
Novel therapies for acute myeloid leukemia. Does age still matter?
1个月前
已完结
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia
1个月前
已完结
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients
1个月前
已完结
Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML
1个月前
已完结
Myelodysplastic syndromes versus acute myeloid leukaemia: biology or blasts-what truly defines the disease and does it matter?
1个月前
已关闭
皖公网安备34019202002308
